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"biological" approach which is less invasive, simpler and cheaper
compared to prosthesis implants. In recent years a great deal has
been learnt about the isolation, cultivation and characterization
of MSCs due to their potential use in regenerative medicine and
tissue engineering. We demonstrated that BMDc have the same
phenotypical and functional characteristics of MSCs but easily
obtainable and usable in a “one step” procedure avoiding cell
isolation and expansion.
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Purpose: Previous studies have pointed to the importance of
subchondral bone restoration in the repair of cartilage defects.
In osteochondral defects, it may be necessary to restore the
underlying bone to facilitate the successful repair of cartilage.
Biodegradable scaffolds and demineralized cortical bone have
been investigated for the repair of focal defects. However, those
materials have had varying levels of success.
This study investigates the use of a novel allograft sponge of dem-
ineralized cancellous bone to ﬁll and repair osteochondral defects
in a goat model. It was hypothesized that the unique properties
of this sponge would facilitate restoration of the subchondral bone
with subsequent ﬁll of the cartilage defect, and support integration
with the surrounding tissues.
Methods: Osteochondral defects (4.5mm Ø, 8mm depth) were
created in the trochlear groove of goats. Two defects were cre-
ated; one defect ﬁlled with acellular allograft sponge (Bacterin) and
the other ﬁlled with an autograft core. The sponge is a demineral-
ized goat cancellous bone plug created similarly to commercially-
available human allograft products (OsteoSponge™. The knee was
splinted for 2 weeks. After 12 months, the animals were sacriﬁced
and the defects underwent macroscopic scoring, MRI morpho-
logical analysis, microCT scanning, and histological scoring. Data
were analyzed using one-way ANOVA with data shown as average
± SD with 4 replicates.
Results: All defects were ﬁlled with white and glistening repair
tissue at 12 months and the defects scored similarly in gross
appearance. Defects were generally ﬁlled with tissue that was
ﬂush to the native cartilage based on histological and MRI analy-
sis. Restoration of bone was similar for the sponge and autograft
groups and all samples demonstrated complete osseous incor-
poration on MRI. Tidemark restoration was partial or complete
for most of the sponge samples. Histological and MRI analysis
demonstrated cartilage repair tissue that resembled hyaline carti-
lage, with histological scores being similar between the groups for
matrix staining, cell morphology, defect architecture, and surface
architecture. Histological scores for integration were signiﬁcantly
higher for the sponge-treated defects when compared to the con-
trols (p<0.001, Fig. 1).
Conclusions: The novel DBM sponge used in this study was
shown to support subchondral bone restoration in focal osteo-
chondral defects and resulted in defect ﬁll similar to that observed
for the autograft controls. The sponge’s unique properties facili-
tated a high-degree of press-ﬁt while conforming to the contour of
the defect. The results achieved with the sponge were statistically
similar to those of the autograft controls in all histological scoring
categories with the exception of integration, where the sponge was
signiﬁcantly better than the controls. Overall, this study demon-
strates the use of a novel sponge to successfully ﬁll osteochondral
Figure 1. MicroCT images, Saf-O stained sections, Col II stained sections,
and Quantitative T1rho images for sponge-treated defects (A–D) and autograft-
treated defects (E–H).
defects, resulting in repair of the defects with tissue similar in
quality to that of autograft-ﬁlled defects and improved integration
with the surrounding cartilage. Further experimentation is needed
to conﬁrm outcome at later timepoints and in larger defects. The
safety and efﬁcacy of the allograft sponge has not been validated
in human joints.
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Purpose: Cartilage repair still remains a challenge to the main
investigators in the ﬁeld. Cellular therapy is long far away from the
desired regeneration of cartilage for cartilage damage. Our goal is
to get MSC from umbilical cord stroma cells and differentiate them
to obtain chondrocyte-like cells which could be able transplanted
in injured joint to regenerate the tissue. Recent studies from
our lab demonstrate that a new model of chondrogenesis in
vitro is possible using conditioned medium through the spheroid
formation.
Methods: The umbilical cord tissues were obtained from cae-
sareans from normal women in the Maternity Facility at Complejo
Hospitalario Universitario A Coruña under the supervision of the
hospital ethic committee. MSC were isolated and growth from
umbilical cord stroma tissue using an enzymatic digestion and
cultured adhered to the plastic plate. After two passages the
cells were characterized by ﬂow cytometry and immunoﬂuores-
cent analysis. Adypogenesis, osteogenesis and chondrogenesis
was induced to test the mesodermic potential of this population.
Chondrogenic process was performed using our model which
consisted in growing the cells during two days in medium with
FCS 15%. After 2 days the medium was replaced by a medium
with KO serum and TGF-β3. Spheroids were formed by two days
in culture and this three-dimensional structure help to produce the
characteristic protein which form part of the extra-cellular matrix of
cartilage. The spheroids were frozen in OCT at 4, 7, 14, 28 and 46
days in deﬁned medium culture for a posterior protein and genetic
expression by immunohistochemistry and RT-PCR analysis.
Results: The cells were positive for undifferentiated markers like
OCT4, STRO1 and Nanog and for MSC markers like CD90 (90%),
CD44 (25%), CD69 (12%) and CD106 (12%), whereas they were
negative for haematopoietic markers like CD34 and CD45 (less
than 4% and 5% respectively). Using a commercial medium to
induce adipogenesis and osteogenesis, we obtained 100% differ-
